The Use of Cefiderocol as Salvage Therapy in an Infant Receiving ECMO and Continuous Renal Replacement Therapy.
Stefania MercadanteCostanza TripicianoLorenza RomaniMatteo Di NardoGabriella BottariBianca Maria GoffredoRaffaele SimeoliIsabella GuzzoLaura LancellaCharalampos AntachopoulosMaia De LucaPublished in: Antibiotics (Basel, Switzerland) (2023)
In healthcare settings, treating multidrug-resistant, Gram-negative bacteria poses a serious challenge, especially in pediatric patients. Our findings suggest that cefiderocol can be considered as an off-label rescue therapy in selected pediatric cases.
Keyphrases
- gram negative
- multidrug resistant
- healthcare
- acute kidney injury
- drug resistant
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- stem cells
- acinetobacter baumannii
- mesenchymal stem cells
- young adults
- klebsiella pneumoniae
- pseudomonas aeruginosa
- social media
- health information
- childhood cancer